Twist Bioscience Corporation Common Stock

TWSTNASDAQUSD
69.22 USD
4.71 (6.37%)AT CLOSE (11:59 AM EDT)
70.68
1.46 (2.12%)
POST MARKET (AS OF 07:51 PM EDT)
Post Market
AS OF 07:51 PM EDT
70.68
1.46 (2.12%)
🔴Market: CLOSED
Open?$72.34
High?$73.70
Low?$68.29
Prev. Close?$73.93
Volume?2.5M
Avg. Volume?1.5M
VWAP?$70.20
Rel. Volume?1.62x
Bid / Ask
Bid?$69.49 × 1.1K
Ask?$71.28 × 100
Spread?$1.79
Midpoint?$70.38
Valuation & Ratios
Market Cap?4.6B
Shares Out?62.3M
Float?52.8M
Float %?86.1%
P/E Ratio?N/A
P/B Ratio?10.12
EPS?-$1.31
Dividend?0.00%
Ex-Dividend?N/A

Twist Bioscience Corporation Common Stock (TWST) is currently trading at $69.22. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". Notable factors include a robust Altman Z-Score, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jun 5, 2026.

RelatedVCYTDNA
News
Profile
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
Employees
979
Market Cap
4.6B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2018-10-31
Address
681 GATEWAY BLVD.
SOUTH SAN FRANCISCO, CA 94080
Phone: 800-719-0671
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+3/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
100
Momentum?
31
Short Sent.?
0
Piotroski F-Score?3/9Weak
Altman Z-Score?9.89Safe
Confidence?55%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?31.42%Squeeze Risk
Short Interest?16.6M
Days to Cover?10.4
Free Float52.8M
Avg Daily Volume1.6M
Settlement Date2026-05-15
Financial Health
Current Ratio?2.70Strong
Quick Ratio?2.42Strong
Cash Ratio?1.02Strong
Debt/Equity?0.03Low
ValuationRICHLY VALUEDvs 2 peers + S&P 500
Score
50/100
P/E?
N/A
P/B?
Peers
33
S&P
19
10.12HIGH
P/S?
Peers
33
S&P
6
11.24HIGH
P/FCF?
N/A
EV/EBITDA?
Peers
100
S&P
97
-42.0CHEAP
EV/Sales?
Peers
33
S&P
9
10.98HIGH
Returns & Efficiency
ROE?
Peers
50
S&P
8
-17.9%WEAK
ROA?
Peers
50
S&P
3
-12.0%WEAK
Cash Flow & Enterprise
FCF?$-100040000
Enterprise Value?$4.5B
Fundamentals ratios updated end of day